A review on genetic polymorphisms associated with splenic hemangioma.

  • Venkata Aksheena Varahi Vedam Department of Pharmacology, ESIC Medical College and Post Graduate Institute of Medical Sciences and Research, K.K. Nagar, Chennai-600078, Tamil Nadu, India.
  • Mohan Krishna Ghanta Department of Pharmacology, MVJ Medical College and Research Hospital, Kolathur PO, Hoskote, Bangalore-562114, Karnataka, India
Keywords: spleen cancers, genetic polymorphisms, hemangioma

Abstract

Splenic tumours are uncommon compared to cancers of other parenchymatous organs. Hemangiomas are characterized as nonlymphocytic tumours. Though splenic hemangiomas are rare, they are caused by melanoma, breast cancer and lung cancer metastasis. This review identifies a few genetic polymorphisms that contribute to spleen cancer in this context.

Published
2022-08-02
How to Cite
Vedam, V. A. V., & Ghanta, M. K. (2022). A review on genetic polymorphisms associated with splenic hemangioma. Polymorphism, 9. Retrieved from https://peerpublishers.com/index.php/snp/article/view/99
Issue
Vol 9 (2022)
Section
Articles

Copyright @ 2020 with Peer Publishers